Vitura Health Ltd (ASX: VIT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Vitura Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $43.04 million
P/E Ratio 11.94
Dividend Yield 0.00%
Shares Outstanding 581.65 million
Earnings per share 0.006
Dividend per share 0.01
Year To Date Return -9.76%
Earnings Yield 8.38%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Vitura Health Ltd (ASX: VIT)
    Latest News

    Three rockets heading to space
    Share Gainers

    3 ASX All Ordinaries shares surging more than 10% today

    These three ASX All Ordinaries shares are trouncing the benchmark index today.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Audinate, Endeavour, IAG, and Vitura Health shares are charging higher

    These ASX shares are starting the week in a very positive fashion...

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Beach, Coles, Cronos Australia, and Woolworths shares are pushing higher

    Investors have been snapping up these shares on Tuesday...

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Cronos Australia, Pilbara Minerals, Sayona Mining, and Strike Energy are dropping

    These ASX shares have tumbled on dropped into the red on Wednesday...

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why Cronos Australia, Mesoblast, Sims, and WAM Research are dropping

    These ASX shares are missing out on the good times today...

    Read more »

    Back view of a man lifting hish hands high in front of hemp plants grown for cannabis.
    Cannabis Shares

    ASX cannabis share Cronos has soared 80% in a month. What's going on?

    This cannabis share has been on fire this month...

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Air New Zealand, Cronos, Soul Patts, and Viva Energy shares are pushing higher

    These ASX shares are having a strong day...

    Read more »

    two men in formal business clothing closely inspect a bud from a cannabis crop.
    Broker Notes

    Bell Potter slaps buy rating on this profitable, dividend-paying ASX cannabis share

    This cannabis share is smoking the market on Monday...

    Read more »

    A man in a horse head mask and suit jumps for joy on a beach.
    Earnings Results

    Guess which company just became the first ASX cannabis share to pay a dividend

    We take a a look at why this ASX cannabis share is having such a good day.

    Read more »

    A man in business suit wearing old fashioned pilot's leather headgear, goggles and scarf bounces on a pogo stick in a dry, arid environment with nothing else around except distant hills in the background.
    Cannabis Shares

    Can ASX cannabis shares ever fully recover?

    We take a look at ASX cannabis shares.

    Read more »

    A man in a horse head mask and suit jumps for joy on a beach.
    Earnings Results

    Guess which ASX cannabis share just rocketed 30%

    Cronos posts earnings today.

    Read more »

    An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
    Cannabis Shares

    Green shoots or just weeds? The outlook for ASX cannabis shares in FY23

    Are cannabis stocks set to rise along with the broader industry in the new financial year?

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2023 $0.0100 100.00% Final 28 Sep 2023
    16 Sep 2022 $0.0100 100.00% Final 11 Oct 2022

    VIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Vitura Health Ltd

    Vitura Health Ltd. operates as a medicinal cannabis company. It engages in product and brand development, outsourced manufacturing and distribution for Australia and target export markets. The company was founded on September 27, 2018 and is headquartered in Melbourne, Australia.

    VIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    07 Feb 2025 $0.07 $0.00 0.00% 77,199 $0.07 $0.08 $0.07
    06 Feb 2025 $0.07 $0.00 0.00% 222,294 $0.07 $0.08 $0.07
    05 Feb 2025 $0.07 $-0.01 -12.66% 115,236 $0.08 $0.08 $0.07
    04 Feb 2025 $0.08 $0.00 0.00% 24,850 $0.08 $0.08 $0.08
    03 Feb 2025 $0.08 $0.00 0.00% 55,483 $0.08 $0.08 $0.08
    31 Jan 2025 $0.08 $0.00 0.00% 193,517 $0.08 $0.08 $0.08
    30 Jan 2025 $0.08 $0.00 0.00% 82,162 $0.08 $0.08 $0.08
    29 Jan 2025 $0.08 $0.00 0.00% 144,744 $0.08 $0.08 $0.07
    28 Jan 2025 $0.08 $-0.01 -12.50% 577,126 $0.08 $0.08 $0.08
    24 Jan 2025 $0.08 $0.00 0.00% 25,195 $0.08 $0.08 $0.08
    23 Jan 2025 $0.08 $0.00 0.00% 54,085 $0.08 $0.08 $0.08
    22 Jan 2025 $0.08 $0.00 0.00% 460,660 $0.08 $0.09 $0.08
    21 Jan 2025 $0.08 $0.00 0.00% 680,656 $0.08 $0.08 $0.08
    20 Jan 2025 $0.08 $0.00 0.00% 145,617 $0.08 $0.08 $0.08
    17 Jan 2025 $0.08 $0.00 0.00% 292,166 $0.08 $0.08 $0.08
    16 Jan 2025 $0.08 $0.00 0.00% 9,264 $0.08 $0.08 $0.08
    15 Jan 2025 $0.08 $0.00 0.00% 61,526 $0.08 $0.08 $0.08
    14 Jan 2025 $0.08 $0.00 0.00% 74,699 $0.08 $0.08 $0.08
    13 Jan 2025 $0.08 $0.00 0.00% 9,299 $0.08 $0.08 $0.08
    10 Jan 2025 $0.08 $-0.01 -11.49% 561,729 $0.08 $0.08 $0.08
    09 Jan 2025 $0.09 $0.00 0.00% 1,000 $0.09 $0.09 $0.09

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    04 Sep 2024 Robert Iervasi Buy 179,200 $15,076
    On-market trade.
    30 May 2024 Jenelle Frewen Buy 190,740 $25,944
    On-market trade.
    28 May 2024 Robert Iervasi Buy 280,250 $24,795
    On-market trade.
    29 Apr 2024 Guy Headley Sell 3,500,000 $385,000
    On-market trade.
    23 Apr 2024 Guy Headley Sell 10,000,000 $1,100,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Shane Francis Tanner Non-Executive Director Oct 2018
    Mr Tanner is an Executive and Director with a record over many years of operating in multiple industries and markets. Shane was formerly CFO of an ASX Top 25 company (Mayne Nickless Limited (ASX: MAY)), as well as the inaugural CEO of Symbion Health (formerly known as Mayne Nickless Diagnostic Services). He also played a role in the float of Optus Communications. Over the past 20 years, Shane has been involved with multiple successful IPOs (including Vitura in November 2019) and many large-scale mergers and acquisitions. He has served as either the Chair or Non-Executive Director on more than ten public company boards and many other private companies.
    Ms Rebecca Jayne Wilson Non-Executive Director Nov 2024
    Ms Wilson is a company director with private, ASX-listed and not for-profit organisations. She is currently the Non-Executive Chair of global healthcare technology company, Alcidion Limited (ASX: ALC), and Ai-enabled technology platform LBT Innovations (ASX: LBT), and a Non-Executive Director of ASX listed enterprise technology company Hansen Technologies (ASX: HSN), and not-for-profit Tomisich Foundation. In an executive career spanning 25 years, she held global leadership roles in marketing communication, brand positioning, investor relations, capital management, and corporate affairs. She has expertise in ESG, complex stakeholder communication, brand awareness, issues, crisis and risk management, transactions, and investor relations. She has experience leading companies in commercial activation phases working with CEOs as both an advisor and Non-Executive Director. Shes worked as a NED since 2017, including Committee representation on Remuneration and Nominations (including as Chair), M&A, ESG, and Audit and Risk.
    Mr Robert Iervasi Non-Executive ChairmanNon-Executive Director Feb 2024
    Mr Iervasi as the former Group CEO and Director of Asahi Beverages, Robert led a diversified consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, he served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation. Robert has successfully driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience and expertise in governance, finance, law, and innovation to Vitura.
    Mr Gerard Paul Fogarty Non-Executive Director Nov 2024
    Mr Fogarty is a non-executive director and CEO.His board and executive roles have a variety of sectors, including national security, industrial relations regulation, work health and safety regulation, compensation and rehabilitation regulation, medical research, human performance research and health insurance. His background spans entities, including statutory authorities, joint ventures, industry bodies, not-for-profits and advisory boards. He was most recently a CEO of a private health insurer.
    Mr Daniel Francis Birch Non-Executive Director Nov 2024
    Mr Birch has 20 years experience advising clients across a range of industries.
    Mr Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO Aug 2020
    -
    Mr Geoff Cockerill Chief Executive Officer Nov 2024
    -
    Geoff Cockerill Chief Executive Officer
    -
    Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO
    -
    Nicola M. Swarbrick Chief Operating Officer
    -
    Ryan Tattle Chief Revenue Officer
    -
    Stefan Schmidt Chief Technology Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Elizabeth Sarah Jansen <Stanford Investment Trust> 118,757,765 20.62%
    Guy Rothwell Headley 95,548,772 16.59%
    Cronos Global Holdings Inc. 55,176,065 9.58%
    Matua Hasyo Charlie Jansen <Whanau Family Trust> 44,117,428 7.66%
    NewSouthern Investment Holdings 1 Pty Ltd <NewSouthern Investment Trust 1> 21,000,000 3.65%
    NewSouthern Investment Holdings A Pty Ltd 18,441,007 3.20%
    Citicorp Nominees Pty Limited 13,225,910 2.31%
    HSBC Custody Nominees (Australia) Limited 11,284,879 1.96%
    Ashanna Pty Ltd 10,766,897 1.87%
    Melbourne Securities Corporation Limited <BV1 Fund A/C> 9,000,000 1.56%
    Stone Group Pty Ltd <Stone Children A/C> 6,377,765 1.11%
    UBS Nominees Pty Ltd 5,833,174 1.01%
    EJ Watson (Medical) Pty Ltd <The EJ Watson Med S/F A/C> 5,000,000 0.87%
    Jessimine Jansen 4,253,379 0.74%
    Hektares SG Holdings Pte Ltd 4,050,940 0.70%
    Daniel Francis Birch <BES A/C> 3,766,498 0.65%
    Craig Graeme Chapman <Nampac Discretionary A/C> 3,500,000 0.61%
    Ryan Tattle 3,451,189 0.60%
    Robert Charles Hussey 3,000,000 0.52%
    William David Copland and Susan Mary Copland David Copland Super fund A/C> 2,484,000 0.43%

    Profile

    since

    Note